Company / Capital Expenditures
ABEONA THERAPEUTICS INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.0M
FY2025
5-year range
$130.0K / $8.0M
FY2021-FY2025
Trend
+2309.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +2309% YoY in FY2025, a notable deviation from the 9-year average annual change of +466%.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +4.8%.
Improved from $130,000 to $8M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +24.3%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.8%, indicating consistent growth.
- In FY2025, capital expenditures increased 2309.4% year-over-year.
- Peak capital expenditures was recorded in FY2018.
- Lowest capital expenditures in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.0M | +2309.4% |
| FY2024 | $331.0K | +154.6% |
| FY2023 | $130.0K | -96.9% |
| FY2022 | $4.2M | +210.7% |
| FY2021 | $1.3M | -78.8% |
| FY2020 | $6.3M | +633.6% |
| FY2019 | $860.0K | -90.7% |
| FY2018 | $9.2M | +974.8% |
| FY2017 | $860.0K | +179.2% |
| FY2016 | $308.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026